Impact of up to 3 years of continuous etrasimod treatment: long-term efficacy results from the ELEVATE UC open-label extension

B E Sands, M C Dubinsky, A Armuzzi, C Ma, I Blumenstein, A Afzali, P Smolinski, M Goetsch, K Lazin, M Keating, M Kudela, C Zang, M Segovia, D Branquinho, J C Woolcott, S Danese, D T Rubin · Zeitschrift für Gastroenterologie · 2026 · Heft 08 · S. e323-e324